HASS Corp. (KOSDAQ:450330)
South Korea · Delayed Price · Currency is KRW 5,070.00
-30.00 (-0.59%)
Sep 1, 2026, 3:30 PM KST
HASS Corp. Revenue
HASS Corp. had revenue of 4.12B KRW in the quarter ending June 30, 2026, a decrease of -10.65%. This brings the company's revenue in the last twelve months to 16.08B, up 2.43% year-over-year. In the year 2025, HASS Corp. had annual revenue of 16.59B with 2.64% growth.
Revenue (ttm)
16.08B
Revenue Growth
+2.43%
P/S Ratio
2.46
Revenue / Employee
151.74M
Employees
106
Market Cap
39.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.59B | 425.99M | 2.64% |
| Dec 31, 2024 | 16.16B | 125.55M | 0.78% |
| Dec 31, 2023 | 16.04B | 1.13B | 7.57% |
| Dec 31, 2022 | 14.91B | 2.31B | 18.37% |
| Dec 31, 2021 | 12.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.12T |
| Celltrion | 4.90T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 254.01B |
| MYUNGMOON Pharm co.,Ltd | 199.82B |
| Aprogen Biologics | 86.18B |
| LabGenomics | 77.64B |
| Tdspharm | 32.90B |